Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Gardner Phyllis, Director. Director active across 1 company, notably Mimedx Group, INC.. Cumulatively, 3 reports have been recorded. History available since 27 May 2021. The latest transaction was disclosed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Phyllis Gardner is a Director at MIMEDX GROUP, INC. She contributes to the strategic direction of the company and decision-making within the board. MIMEDX GROUP specializes in biomaterials and regenerative therapies. Phyllis Gardner brings valuable expertise in health and life sciences, thereby helping to guide the company's strategy.